Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 05/26/23 01:30:00 on US and Canada Markets.
Presentations include new data further demonstrating the immune responses induced by TG4001 and recently updated results from the adjuvant Phase I trial of neoantigen vaccine TG4050 in head and neck cancer Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that desi...
Presentations include new data further demonstrating the immune responses induced by TG4001 and recently updated results from the adjuvant Phase I trial of neoantigen vaccine TG4050 in head and neck cancer Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that desi...
GENEVA, SWITZERLAND / ACCESSWIRE / May 26, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFFD )(OTCQB: RLFTD ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to b...
The ‘Coming To A Storm Near You’ launch was the second of two dedicated Electron launches to deploy a constellation of hurricane monitoring satellites for NASA Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a leading launch...
SAR’579/IPH6101, ANKET ® platform lead asset, is a trifunctional anti-CD123 NKp46×CD16 NK cell engager from a joint research collaboration between Innate Pharma and Sanofi, now under development by partner Sanofi Preliminary data published show SAR’579 was ...
SAR’579/IPH6101, ANKET ® platform lead asset, is a trifunctional anti-CD123 NKp46×CD16 NK cell engager from a joint research collaboration between Innate Pharma and Sanofi, now under development by partner Sanofi Preliminary data published show SAR’579 was ...
– If Granted by the European Commission, Veklury will become the First and Only Authorized Antiviral Treatment Across All Stages of Renal Disease – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...
WALTHAM, Mass., May 26, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the pricing of an...
New Found Gold Corp. (“ New Found ”) reports that on May 25, 2023 (the “ Closing Date ”), it acquired control of 28,612,500 common shares (each, a “ Kirkland Share ”) in the capital of Kirkland Lake Discoveries Corp. (“ Kirkland ...
The latest crash-test achievement joins the announcements made late last year of the FF91’s EPA rating of 381 miles of EV range and the official CARB certification received as a zero-emissions vehicle. The first phase of the Company’s three-phase delivery plan set to begin on Ma...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
13.31%Change Percent:
Vontier Corporation Company Name:
VNT Stock Symbol:
NYSE Market:
vontier.com Website: